Skip to main content
Medical Mycology Case Reports logoLink to Medical Mycology Case Reports
. 2017 Feb 5;15:21–24. doi: 10.1016/j.mmcr.2017.02.001

A rare fungal infection: Phaehyphomycosis due to Veronaea botryosa and review of literature

Anne Welfringer a,, Valérie Vuong a, Nicolas Argy b, Christian Chochillon b, Lydia Deschamps c, Guillaume Rollin d, Stanislas Harent d, Véronique Joly d, William Vindrios d, Vincent Descamps a
PMCID: PMC5300299  PMID: 28217435

Abstract

We report a rare case of phaehyphomycosis in a 71-year-old heart transplant recipient Togo native patient. Four months after the transplant, he presented painless nodules on the right heel with superficial ulceration. The polyphasic identification uncovered a rare cause of phaehyphomycose: V. botryosa. The treatment combined surgical excision of the lesions and anti-fungal therapy with posaconazole. We discussed eleven reported cases in literature since 1990.

Keywords: Phaeohyphomycosis, Immunosuppression, Heart transplant recipient, V. botryosa

1. Introduction

Infectious complications, especially fungal, are common in transplant recipients due to the underlying immunosuppression. We report a rare case of phaehyphomycosis Veronaea (V.) botryosa in a heart transplant recipient. The originality of this phaehyphomycosis is the rarity of the species identified. In the literature, 11 other cases of V. botryosa-induced cutaneous phaeohyphomycosis have been reported since 1990 including 3 cases in transplant recipients. This case highlighted the importance of careful research of fungal infection in immunocompromised transplant recipients and monitoring of the immunosuppressive regimen.

2. Case

A 71 year old native Togo patient, who has been living in France since 1970 and has not been back to Africa for 20 years, also a heart transplant recipient, was hospitalized for nodules on his right heel. The nodules were painless and slowly progressive with superficial ulceration (1A and 1B). His significant medical history included hypertension, insulin-dependent diabetes mellitus, and ventricular tachycardia with implantable defibrillator. He had a history of hypertrophic cardiomyopathy that required a heart transplantation on May 2014 (day 1), and was complicated by several bacterial infections (Enterobacter cloacae, Enterococcus faecalis, Pseudomonas aeruginosa), fungal infections (Fusarium sp. ascites), and a postoperative CMV reactivation. His immunosuppressive treatment included mycophenolate mofetil 500 mg×2/d, corticosteroids 10 mg/d, and cyclosporine 125 mg×2/d, (concentration of 197 ng/ml target 200–250). The skin nodules developed a few months after transplantation, on August 2014. In December 2014 (day 210), histological analysis of skin biopsy demonstrated multinucleated giant cells, epidermal hyperplasia, abscesses with neutrophil infiltrates (1C) and pigmented conidia with positive Grocott staining (1D).

The isolate was sent to the National Reference Center for Invasive Mycoses and Antifungals (NRCMA), Institut Pasteur, Paris, for speciation. The microscopic examination of a velvety blackish-brown colony on 2% malt agar (MEA), revealed straight to flexuous, smooth-walled melanized conidiophores (2A and 2B). Conidiogenous cells were mostly terminal, bearing 1-septate smooth-walled cylindrical conidia truncated at the base. On the basis of its morphological features, the filamentous fungus was identified as Veronaea botryosa. Molecular confirmation was ascertained by the amplification and sequencing of the ITS1-5.8S-ITS2 region of the ribosomal DNA [1]. Comparison of the nucleotide sequence of the isolate (623 bp) with GenBank database showed a 99.8% identity (623/622) with V. botryosa type strain CBS 254.57 (GenBank NR_103593.1).

Due to the immunodeficiency of the patient, a staging was performed (PET scan and brain imaging) which returned normal. Lymphopenia (210/mm3) was noted in the blood test. The treatment included surgical excision of the lesions and anti-fungal therapy with posaconazole 400 mg twice a day for 3 months. The evolution of the lesions was favorable, but a few months later (day 330), the patient died from septic shock (Klebsiella pneumonia and Escherichia coli septicemia) (Fig. 1, Fig. 2).

Fig. 1.

Fig. 1.

painless nodules, with superficial ulceration (1A and 1B). (1C and 1D) original magnification ×400 Histological analysis of skin biopsy demonstrated multinucleated giant cells containing pigmented spores, (hematoxylin eosin stain) (1C) Grocott staining showed numerous spores (1D).

Fig. 2.

Fig. 2.

Culture on Sabouraud chloramphenicol at 27 °C (2A). Micromorphology of conidiophores, conidiogenous cells and conidia of V. botryose (2B).

3. Discussion

Phaehyphomycosis is defined by the presence of melanized yeast-like cells or hyphae in tissues. Patients diagnosed with phaeohyphomycosis are often immunocompromised (diabetics, transplant recipients, patients on immunosuppressive drugs or steroids). These fungi induce subcutaneous and systemic opportunistic and cosmopolitan infections [2]. They are saprophyte of plants, water, and earth. Their transmission mode is land-based, through contaminated water or vegetable items. The melanin present in the cell wall is a known virulence factor. The physiopathology of the infection remains unclear, but some authors speculate that the organism is acquired previously, remained quiescent, and is reactivated due to immunosuppression [3]. [4], The uniqueness of this phaehyphomycosis case is that the species found is extremely rare. To date, only 11 cases of V. botryosa-induced cutaneous phaeohyphomycosis have been reported since 1990. We report here the main characteristics of these patients (Table 1): most patients were natives from Asia, the mean (age: 51,7 years old, and most of them were males (8 men/12 cases with our case). This is the third reported case of V. botryosa infection in a transplant-recipient. The clinical presentation was papulo-nodules or ulcerations, mainly on the lower limbs. All patients were treated by anti-fungals and four with surgery leading to a favorable outcome with resolution of the lesions for 7 patients.

Table 1.

Reported cases of V. botryosa induced cutaneous phaeohyphomycosis.

Case (ref.) Years age/Sex Country origin Immunosuppression/comorbidities Soil or plant exposure Clinical presentation Treatment Follow-up
1/[6] 1990 24M China NA Farmer Black, verrucous nodules and cysts on back of hands, cheeks, and forearm AmB and lesional excision without efficacy; NA
2/[7] 1995 28F Libya NA NA Nodular-ulceronodular lesions on thumb and fifth finger, upper limb, nasal mucosa, and palate NA NA
3/[8] 1998 37M Philippines NA No erythematous, pruritic papules on the right deltoid and left shin Itracozazole Healing
4/[3] 1999 57M France Liver transplant: appearance of lesions 11 weeks after transplantation No Multiple painless dermal nodules that coalesced and spontaneously yielded pus Itraconazole Healing
5/[9] 2003 81M Taiwan No/Chronic renale failure Farmer Swelling plaque, papulonodules on Left leg and dorsal foot Debridement and Itraconazole Healing
6/[10] 2003 12M China Unknown No Disseminated nodular lesions on face, upper limbs, legs, scrotum, and buttocks Herbal medication thermotherapy, local AmB injection; Terbinafine, itraconazole No effect
7/[4] 2004 62M USA Heart transplant No Area of chronic induration and tenderness over the dorsum of the right hand Itraconazole and Vorinonazole (gastrointestinal complaints) and incision Healing
8/[11] 2006 76M Taiwan No Farmer Crusted nodules and plaques. Right forearm and knee, left upper limb Itraconazole/amB No effect
9/[12] 2007 65F Japan VHC Farmer A erythematous, slightly scaly, indurated plaque on the dorsum of the left wrist of more than 3 years’ duration Surgical excision Healing
10/[13] 2010 16F China No No crusted, verrucous lesions, initially on the left ear and later on the left buttock Itraconazole Healing
within 2–5 months of receiving an ear piercing
11/[14] 2012 32F Mexico aggravated by pregnancy No Chronic dermatosis which started Posaconazole Improvement of the lesions
10 years earlier with multiple Exophytic, multilobulated, soft, and penduculated or sessile neoformations of diverse sizes from 2 to 10 cm in diameter, which became verrucose and increased in size.
12/[15]: Case reported in this article 2015 71M France Heart Transplant, four months after the transplant NO Painless, slowly progressive on the leg with superficial ulceration Excision and Posaconazole Death

V. botryosa can induce both chromoblastomycosis (chronic disease of the skin and subcutaneous tissues in tropical regions characterized by the presence of fumagoid cells and phaeohyphomycosis). The clinical presentation of phaehyphomycosis is polymorphic (only skin involvement, systemic, superficial, or deep infection). It requires both histopathological and mycological analysis. Histological diagnostic criteria include the presence of brown hyphae, septate vesicular thickened wall to dark brown accompanied by yeast-like elements poorly systematized in an inflammatory granuloma. The cell wall is pigmented and stained by Gomori Grocott. Histology displays a cystic abscess with granulomatous reaction. Identification of the species involved is essential since many different species can be responsible for phaeohyphomycosis. Lack of sporulation for the isolate prevented antifungal susceptibility testing. However, previous studies have shown that the species usually exhibits high minimal inhibitory concentrations (MIC) of amphotericin B, terbinafine, voriconazole and echinocandins with lower MICs of itraconazole and posaconazole [5]. The patient was thus prescribed posaconazole together with surgical resection of the lesion. Most of the cases reported were only prescribed antifungal drugs. Phaeohyphomycosis should be kept in mind in transplant recipients.

Conflict of Interest

There are none.

Acknowledgements

We thank Dea Garcia-Hermoso (National Reference Center for Invasive Mycoses & Antifungals, Molecular Mycology unit, Institut Pasteur, Paris, France) for identification of the isolate and for the picture.

We thank Virginia Nguyen (Department of cardiology, Hospital Bichat, University Paris Diderot, Paris).

References

  • 1.Alvarez E., Garcia-Hermoso D., Sutton D.A., Cano J.F., Stchigel A.M., Hoinard D. Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J. Clin. Microbiol. 2010;48(12):4410–4416. doi: 10.1128/JCM.01646-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.K. Nishimura, M. Miyaji, H. Taguchi, D. L. Wang, R. Y. Li, and Z. H. Meng. An ecological study on pathogenic dematiaceous fungi in China, p. 17-20. In Current problems of opportunistic fungal infections, 1989
  • 3.Foulet F., Duvoux C., de Bièvre C., Hézode C., Bretagne S. Cutaneous phaeohyphomycosis caused by Veronaea bothryosa in a liver transplant recipient successfully treated with itraconazole. Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am. 1999;29(3):689–690. doi: 10.1086/598660. [DOI] [PubMed] [Google Scholar]
  • 4.Sutton D.A., Rinaldi M.G., Kielhofner M. First U.S. report of subcutaneous phaeohyphomycosis caused by Veronaea botryosa in a heart transplant recipient and review of the literature. J. Clin. Microbiol. 2004;42(6):2843–2846. doi: 10.1128/JCM.42.6.2843-2846.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Badali H., Yazdanparast S.A., Bonifaz A., Mousavi B., de Hoog G.S., Klaassen C.H.W. Veronaea botryosa: molecular identification with amplified fragment length polymorphism (AFLP) and in vitro antifungal susceptibility. Mycopathologia. 2013;175(5–6):505–513. doi: 10.1007/s11046-013-9631-6. [DOI] [PubMed] [Google Scholar]
  • 6.Zhang H.E., Wang D.L., Li R.Y. Report of the case of phaeohyphomycosis caused by Veronaea botryosa. Chin. J. Dermatol. 1990;23:96–98. [Google Scholar]
  • 7.Ayadi A., Huerre M.R., de Bievre C. Phaehyphomycosis caused by Veronea bothryosa. Lancet Lond. Engl. 23. 1995;346(8991–8992):1703–1704. doi: 10.1016/s0140-6736(95)92866-9. [DOI] [PubMed] [Google Scholar]
  • 8.A.L. Medina, J.A.D. Redondo, L.M. Nebrida, Two unusual cases of mycoses in the Philippines. p. 88. In Proceedings of the 4th China Japan International Congress on Mycology, 1998.
  • 9.C. Chen, Y. Tsai, S. Hu Cutaneous Veronaea botryosa phaeohyphomycosis manifested as lymphocutaneous syndrome, 21, pp. 375–383
  • 10.Matsushita A., Jilong L., Hiruma M., Kobayashi M., Matsumoto T., Ogawa H. Subcutaneous phaeohyphomycosis caused by Veronaea botryosa in the People's Republic of China. J. Clin. Microbiol. 2003;41(5):2219–2222. doi: 10.1128/JCM.41.5.2219-2222.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chen Y.-T., Lin H.-C., Huang C.-C., Lo Y.-H. Cutaneous phaeohyphomycosis caused by an Itraconazole and Amphoterecin B resistant strain of Veronaeae botryosa. Int J. Dermatol. 2006;45(4):429–432. doi: 10.1111/j.1365-4632.2006.02619.x. [DOI] [PubMed] [Google Scholar]
  • 12.Kondo Y., Hiruma M., Matsushita A., Matsuba S., Nishimura K., Takamori K. Cutaneous phaeohyphomycosis caused by Veronaea botryosa observed as sclerotic cells in tissue. Int J. Dermatol. 2007;46(6):625–627. doi: 10.1111/j.1365-4632.2007.02950.x. [DOI] [PubMed] [Google Scholar]
  • 13.Sang H., Zheng X.E., Kong Q.T., Zhou W.Q., He W., Lv G.X. A rare complication of ear piercing: a case of subcutaneous phaeohyphomycosis caused by Veronaea botryosa in China. Med Mycol. 2011;49(3):296–302. doi: 10.3109/13693786.2010.513340. [DOI] [PubMed] [Google Scholar]
  • 14.Bonifaz A., Davoudi M.M., de Hoog G.S., Padilla-Desgarennes C., Vázquez-González D., Navarrete G. Severe disseminated phaeohyphomycosis in an immunocompetent patient caused by Veronaea botryosa. Mycopathologia. 2013;175(5–6):497–503. doi: 10.1007/s11046-013-9632-5. [DOI] [PubMed] [Google Scholar]
  • 15.Chochillon C., Lorme F., Vindrios W., Descamps L., Dromer F., Houze S. Phaehyphomycose: un cas à Veronaea botryosa. J. Med Mycol. 2015;25(3):239. [Google Scholar]

Articles from Medical Mycology Case Reports are provided here courtesy of Elsevier

RESOURCES